Viewing nowPioglitazone 15 mg
Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 200702710 · Approved 2007.03.05 · Insurance code 657303580
Improvement of type 2 diabetes (blood sugar control)
This medication assists in blood sugar control for type 2 diabetes patients by supplementing dietary and exercise therapies. It can be used alone or in combination with sulfonylureas, metformin, or insulin if there is no effect after using other oral hypoglycemic agents. Additionally, diabetes patients should receive nutritional counseling, weight loss, and regular exercise therapy, as these efforts are crucial not only for initial treatment but also for maintaining the efficacy of the medication. This medication is used to improve blood sugar control in type 2 diabetes patients.
This medication is administered orally once a day, regardless of meals. 1. Monotherapy: Start with 15 mg once a day, and if there is insufficient effect, the dose may be increased to 30 mg once a day. 2. Combination therapy: - When used with sulfonylureas, the initial dose is 15 mg once a day. - When used with metformin, the initial dose is 15 mg once a day. - When used with insulin.
There is no experience in using this medication in children under 18 years of age, so administration is not recommended.
This medication helps control blood sugar in type 2 diabetes patients. However, it should not be taken by patients with heart failure or those with a history of heart failure, as it may exacerbate the condition. Furthermore, this medication may cause fluid retention, leading to swelling or weight gain; if symptoms of swelling occur, consult a physician immediately. Patients with a history of heart disease, hypertension, or myocardial infarction should be particularly cautious, and if symptoms such as shortness of breath, swelling, or rapid weight gain appear during treatment, they should inform healthcare personnel immediately. This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and immediate consultation with a physician is necessary if symptoms like urination difficulties or hematuria occur. It is also advised not to administer this medication to patients with severely impaired liver or kidney function, and if symptoms of liver dysfunction arise, testing should be conducted, and the medication should be discontinued if necessary. The risk of hypoglycemia may increase when used with other hypoglycemic agents; therefore, caution should be exercised regarding hypoglycemia symptoms, and adjustments to the dosages of other medications may be necessary. For premenopausal women, this medication may stimulate ovulation, thereby increasing the risk of pregnancy; appropriate contraception is recommended. Women who are pregnant or may become pregnant should avoid this medication, and those who are breastfeeding should consult with a physician. Elderly or malnourished patients may be at higher risk for hypoglycemia or side effects, so caution is needed. During treatment, regular monitoring of blood sugar and liver function is necessary, and any changes in physical condition should be reported to healthcare personnel promptly. This medication is taken once a day, and if a dose is missed, do not double the dose the next day. Finally, it is not used in children as safety and efficacy have not been established.
Congestive heart failure (including severe swelling and difficulty breathing), symptoms and signs of heart failure, worsening of heart failure, cardiovascular abnormalities, myocardial infarction, stroke, severe edema or urinary abnormalities (visible hematuria, urination difficulties, urgency), severe allergic reactions (urticaria), severe skin adverse reactions, liver abnormalities (jaundice, liver failure, worsening of liver disease), severe neurological symptoms (stroke, thunderclap headache), respiratory problems (shortness of breath or difficulty breathing)
Not everyone experiences these, and they can vary from person to person.
Store this medication in a container that can block light and air, and ensure it is protected from moisture. The storage temperature should be between 15 to 30 degrees Celsius, with around 25 degrees being ideal.
White to off-white, round, convex tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.